Nutra Pharma Corp (NPHC) Cash from Investing Activities (2016 - 2025)

Nutra Pharma has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$25000.0 for Q2 2025.

• In Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$25000.0; the TTM figure through Dec 2025 stood at -$51052.0 (down 132.01% YoY), while the FY2025 annual figure was -$51052.0, down 223.61% from the prior year.
• Cash from Investing Activities came in at -$25000.0 for Q2 2025 at Nutra Pharma, up from -$26052.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $83649.0 in Q4 2023 to a low of -$142214.0 in Q2 2021.
• Average Cash from Investing Activities over 5 years is -$9852.1, with a median of -$10155.0 recorded in 2022.
• Year-over-year, Cash from Investing Activities jumped 416.44% in 2022 and tumbled 90.08% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$16275.0 in 2021, then jumped by 416.44% to $51500.0 in 2022, then soared by 62.43% to $83649.0 in 2023, then plunged by 90.08% to $8300.0 in 2024, then sank by 401.2% to -$25000.0 in 2025.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$25000.0 in Q2 2025, -$26052.0 in Q1 2025, and $8300.0 in Q4 2024.